SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001609251-16-000008
Filing Date
2016-02-17
Accepted
2016-02-16 21:08:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 KRENSAVAGE ASSET MANAGEMENT BIOTA 13G/A 12.31.2015 biota13g.txt SC 13G/A 16105
  Complete submission text file 0001609251-16-000008.txt   17935
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-31596 | Film No.: 161431386
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 130 EAST 59TH STREET 11TH FLOOR NEW YORK NY 10022
Business Address 130 EAST 59TH STREET 11TH FLOOR NEW YORK NY 10022 212-888-1582
Krensavage Asset Management, LLC (Filed by) CIK: 0001609251 (see all company filings)

IRS No.: 262520930 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A